Gsta1 Antibody

What is GSTA1 and what are its primary biological functions?

GSTA1 is a glutathione S-transferase that catalyzes the nucleophilic attack of the sulfur atom of glutathione on electrophilic groups of various exogenous and endogenous compounds. It plays multiple biological roles including: formation of glutathione conjugates with prostaglandins A2 and J2, catalyzing the isomerization of D5-androstene-3,17-dione (AD) into D4-androstene-3,17-dione (potentially significant in hormone biosynthesis), and contributing to oxidized linoleic acid metabolism through glutathione-dependent peroxidase activity toward fatty acid hydroperoxides like 13-HPODE . These diverse functions position GSTA1 as a critical enzyme in both cellular protection and metabolism.

What experimental applications is GSTA1 antibody suitable for?

GSTA1 antibodies have been validated for multiple experimental applications including Western blotting (WB), immunohistochemistry on paraffin-embedded sections (IHC-P), and immunocytochemistry/immunofluorescence (ICC/IF). For example, antibodies like ab53940 have demonstrated reactivity with recombinant full-length protein, as well as GSTA1 from multiple species including human, mouse, rat, hamster, and rabbit samples . The choice of application should be guided by the specific research question and appropriate validation controls.

What factors should be considered when selecting a GSTA1 antibody?

When selecting a GSTA1 antibody, researchers should consider: (1) Host species and clonality (e.g., goat polyclonal antibodies like ab53940) ; (2) Validated applications (WB, IHC-P, ICC/IF); (3) Species reactivity (human, rat, mouse, etc.); (4) Previous citation record in peer-reviewed literature; (5) Immunogen information (e.g., native full-length protein); and (6) Whether carrier-free options are available for specialized applications. Antibody dilution factors vary by application - for example, 1:2000 dilution may be recommended for ECL methods in Western blotting with overnight incubation .

How is GSTA1 involved in hepatic lipid metabolism?

GSTA1 plays a protective role against hepatic lipid accumulation. Research demonstrates that GSTA1 directly interacts with fatty acid binding protein 1 (FABP1) to promote its degradation, thereby interfering with the uptake and transportation of free fatty acids and inhibiting intracellular triglyceride (TG) synthesis . Experimental evidence shows that overexpression of GSTA1 significantly alleviated steatosis induced by oleic acid in hepatocytes and by high-fat diet in mouse liver models. Mechanistically, GSTA1 has no effect on TG degradation but rather inhibits TG synthesis by downregulating genes involved in fatty acid esterification (SCD1, GPAT3, LIPIN, DGAT1/2), de novo lipogenesis (ACSS2/3, SREBP1, FAS), and fatty acid β-oxidation (CPT1A, ACOX1, ACC2) .

How does GSTA1 affect cellular differentiation processes?

GSTA1 levels appear to modulate enterocyte proliferation and are associated with differentiation processes. In human colonic adenocarcinoma (Caco-2) cells, spontaneous differentiation into mature enterocytes correlates with progressive increases in GSTA1 expression . Experimental evidence demonstrates increased GSTA1 levels associated with decreased proliferation and increased expression of differentiation markers including alkaline phosphatase, villin, dipeptidyl peptidase-4, and E-cadherin in postconfluent Caco-2 cells . Notably, forced expression of GSTA1 significantly reduces cellular proliferation, while siRNA-mediated down-regulation of GSTA1 significantly increases cells in S-phase and associated cell proliferation, suggesting GSTA1's direct involvement in cell cycle regulation .

What signaling pathways does GSTA1 interact with?

GSTA1 has been shown to interact with several important signaling pathways. In HCC, GSTA1 appears to suppress tumorigenesis by targeting the AMPK/mTOR pathway . Western blot analysis has demonstrated that LKB1 and phosphorylated AMPK were upregulated while phosphorylated mTOR, phosphorylated p70 S6 Kinase, and MMP-9 were downregulated in cells with high GSTA1 expression . Additionally, GSTA1 interacts with JNK signaling, as evidenced by GSTA1-JNK complex dissociation following sodium butyrate (NaB) treatment, although JNK phosphorylation was not altered in this context . These interactions suggest GSTA1 may integrate with multiple signaling networks to influence cellular fate.

How does the GSTA1-FABP1 interaction influence cellular metabolism?

The direct interaction between GSTA1 and FABP1 represents a novel mechanism by which GSTA1 regulates lipid metabolism. Protein interaction database STRING shows a high binding coefficient of 0.805 between GSTA1 and FABP1 . This interaction has been experimentally validated through co-immunoprecipitation studies and immunofluorescence staining showing co-localization of GSTA1 and FABP1 in the cytosol of L02 cells . Functionally, this interaction promotes FABP1 degradation, thereby interfering with free fatty acid uptake and transportation, which inhibits intracellular triglyceride synthesis. This mechanism provides a molecular basis for GSTA1's protective effect against hepatic steatosis and metabolic dysfunction .

What are the optimal protocols for using GSTA1 antibody in Western blot?

For Western blot applications with GSTA1 antibody, researchers should follow these optimized protocols: (1) Separate protein samples using SDS-PAGE and transfer to nitrocellulose membranes; (2) Block membranes with 5% non-fat milk in Tris-buffered saline containing 0.1% Tween-20 for 2 hours at room temperature; (3) Incubate with primary anti-GSTA1 antibody (e.g., NBP-33586 at 1:1000 dilution) overnight at 4°C; (4) Probe with appropriate secondary antibody for 1 hour; (5) Visualize using enhanced chemiluminescence detection method (e.g., Pierce ECL Western Blotting Substrate) . For ECL methods, a 1:2000 dilution with overnight incubation at room temperature has been effective with antibodies like ab53940 . Expected band size for GSTA1 is approximately 25 kDa .

How should I optimize immunohistochemistry protocols for GSTA1 detection?

For immunohistochemistry detection of GSTA1, the following protocol has been validated: (1) Prepare tissue microarray (TMA) or individual slides; (2) Incubate with rabbit polyclonal primary antibody against GSTA1 (e.g., NBP-33586, 1:2000 dilution) overnight at 4°C in a moist chamber; (3) Conjugate with appropriate secondary antibody (e.g., NB7156, 1:2000 dilution) for 60 minutes at room temperature; (4) Stain for 15 seconds using DAB Kit . For scoring, a standardized system can be employed where staining intensity is scored as 0 (negative), 1 (weak), 2 (moderate), or 3 (strong), and staining extent as 1 (<25%), 2 (25%-50%), 3 (51%-75%), or 4 (>75%). The final GSTA1 expression score can be calculated as intensity score × extent score, ranging from 0 to 12 .

What are the considerations for immunofluorescence applications of GSTA1 antibody?

For immunofluorescence applications with GSTA1 antibody, consider this validated protocol: (1) Fix cells with 4% formaldehyde for 10 minutes; (2) Permeabilize cells and block non-specific binding by incubating in 1% BSA/10% normal serum/0.3M glycine in 0.1% PBS-Tween for 1 hour; (3) Incubate with GSTA1 antibody (e.g., ab53940 at 5μg/ml) overnight at 4°C; (4) Incubate with fluorescently labeled secondary antibody (e.g., Alexa Fluor® 488 donkey anti-goat IgG at 1:1000 dilution) for 1 hour; (5) Use appropriate counterstains for plasma membranes (e.g., Alexa Fluor® 594 WGA at 1:200) and nuclei (e.g., DAPI at 1.43μM) . This approach has been successful in HepG2 cells and can be adapted for other cell types with appropriate optimization.

How can GSTA1 expression be manipulated for functional studies?

GSTA1 expression can be effectively manipulated through several approaches for functional studies: (1) Overexpression using lentiviral vectors carrying the GSTA1 gene, which has been successfully employed in liver cancer cell lines like 97H and SNU449 ; (2) siRNA-mediated down-regulation, which has been shown to increase cell proliferation and S-phase cells in Caco-2 models ; (3) Pharmacological induction, as demonstrated with bicyclol treatment which upregulates GSTA1 expression . These approaches allow researchers to investigate the functional consequences of altered GSTA1 levels in various cellular processes including proliferation, differentiation, metabolism, and cancer progression.

How should contradictory findings about GSTA1's role in cancer be interpreted?

Research suggests that GSTA1 can have both stimulatory and inhibitory effects on tumorigenesis depending on context . When interpreting contradictory findings, researchers should consider: (1) Tissue specificity - GSTA1's effects may differ between tissue types; (2) Cancer stage and type - GSTA1 may play different roles in initiation versus progression; (3) Genetic background - GSTA1 polymorphisms have been associated with cancer susceptibility ; (4) Experimental models - in vitro versus in vivo findings may differ; (5) Interaction with other signaling pathways - GSTA1's effects may be modulated by the tumor microenvironment and concurrent signaling events. For comprehensive understanding, researchers should design experiments that account for these variables and combine multiple approaches including clinical correlation, mechanistic studies, and functional validation.